Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Glucose concentrations were also not affected by sitagliptin treatment
Side effects like nausea and vomiting are common
96% Natural Origin Ingredients
accredited labs 99%+ purity HPLC verified 3x TRIPLE AGONIST GLP-1, GIP, and glucagon receptors 24% BODY WEIGHT Reduction in Phase 2 trials (retatrutide) 50+ PUBLICATIONS Rapidly growing research base 2023 PHASE 2 DATA Presented at ADA conference 39AA SEQUENCE Modified triple-agonist peptide Free shipping on orders over $150 Quality guarantee 99%+ purity verified Secure checkout 256-bit SSL encryption Research GLP-3 R (CAS 2381089-83-2) is the research designation applied to the synthetic triple-receptor agonist peptide also catalogued as retatrutide / LY3437943
US$ 23.47
US$ 25.82
US$ 27.57
US$ 28.13
US$ 29.23
US$ 21.57
US$ 28.73
